| Literature DB >> 35901060 |
Shujian Zhang1, Han Jin1,2, Junlong Da1, Kai Zhang1, Lixue Liu1, Yuyao Guo1, Wenxuan Zhang1, Yawei Geng1, Xinpeng Liu1, Jiahui Zhang1, Lili Jiang1, Haoze Yuan1, Jianqun Wang1, Yuanbo Zhan1,3, Ying Li1,2, Bin Zhang1,2.
Abstract
BACKGROUND: Cell survival or death is one of the key scientific issues of inflammatory response. To regulate cell death during the occurrence and development of periodontitis, various forms of programmed cell death, such as pyroptosis, ferroptosis, necroptosis, and apoptosis, have been proposed. It has been found that ferroptosis characterized by iron-dependent lipid peroxidation is involved in cancer, degenerative brain diseases and inflammatory diseases. Furthermore, NCOA4 is considered one of ferroptosis-related genes (FRGs) contributing to butyrate-induced cell death in the periodontitis. This research aims to analyze the expression of FRGs in periodontitis tissues and to explore the relationship between ferroptosis and periodontitis.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35901060 PMCID: PMC9333299 DOI: 10.1371/journal.pone.0271202
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
The data obtained from GEO.
| GEO gene set ID | GSE16134 | GSE10334 |
|---|---|---|
| Platform | GPL570: [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array | |
| Number of Affected sites vs. Unaffected sites | 241 vs. 69 | 183 vs. 64 |
| Clinical Data | ||
| Affected sites | Probing Depth > 4 mm, Clinical Attachment Loss ≥ 3 mm, with Bleeding on Probing | Probing Depth > 4 mm, Clinical Attachment Loss ≥ 3 mm, with Bleeding on Probing |
| Unaffected sites | Probing Depth ≤ 4 mm, Clinical Attachment Loss ≤ 2 mm, no Bleeding on Probing | Probing Depth ≤ 4 mm, Clinical Attachment Loss ≤ 2 mm, no Bleeding on Probing |
| Smoking | Not | Not |
PCR primer sequences.
| Gene | Forward Primer (5’ to 3’) | Reverse Primer (5’ to 3’) |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Up/Downregulated DEGs.
| Gene symbol | Adjusted P-value | Fold change | Gene title |
|---|---|---|---|
|
| 3.92E-57 | 1.553844 | adenosine deaminase 2 |
|
| 7.42E-58 | 1.588507 | basic helix-loop-helix family, member a15 |
|
| 1.07E-48 | 1.162589 | BTG family, member 2 |
|
| 3.83E-56 | 1.559668 | chromosome 16 open reading frame 54 |
|
| 9.22E-53 | 1.185639 | complement component 3 |
|
| 1.95E-59 | 1.205283 | complement component 4B (Chido blood group) |
|
| 1.34E-43 | 1.131173 | chemokine (C-C motif) ligand 18 |
|
| 3.80E-53 | 1.133135 | cellular communication network factor 1 |
|
| 4.85E-57 | 1.01127 | cellular communication network factor 2 |
|
| 8.00E-57 | 1.096126 | CD177 molecule |
|
| 3.41E-64 | 1.192922 | CD19 molecule |
|
| 1.81E-45 | 1.813238 | CD27 molecule |
|
| 8.02E-43 | 1.551755 | CD38 molecule |
|
| 5.19E-50 | 1.947502 | CD79a molecule, immunoglobulin-associated alpha |
|
| 6.18E-44 | 1.00665 | complement factor I |
|
| 3.12E-41 | 1.205063 | collagen, type XV, alpha 1 |
|
| 4.04E-54 | 1.160181 | collagen, type IV, alpha 1 |
|
| 3.09E-46 | 1.1936 | collagen, type IV, alpha 2 |
|
| 8.85E-43 | 1.042673 | coronin, actin binding protein, 1A |
|
| 5.56E-53 | 1.308945 | copine V |
|
| 1.49E-32 | 1.173406 | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
|
| 6.58E-29 | 1.259706 | colony stimulating factor 3 |
|
| 1.38E-52 | 1.034782 | cathepsin H |
|
| 9.72E-45 | 1.891672 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
| 1.96E-57 | 1.075039 | chemokine (C-X-C motif) ligand 12 |
|
| 4.72E-53 | 1.392421 | chemokine (C-X-C motif) ligand 13 |
|
| 2.39E-38 | 2.008496 | chemokine (C-X-C motif) ligand 6 |
|
| 8.48E-35 | 1.275532 | chemokine (C-X-C motif) ligand 8 |
|
| 4.07E-41 | 1.763415 | chemokine (C-X-C motif) receptor 4 |
|
| 1.45E-48 | 1.376211 | cytochrome P450, family 24, subfamily A, polypeptide 1 |
|
| 6.14E-57 | 1.615435 | cytohesin 1 interacting protein |
|
| 1.16E-60 | 1.051272 | DNA-damage-inducible transcript 4-like |
|
| 5.72E-39 | 1.013822 | derlin 3 |
|
| 1.63E-53 | 1.022911 | DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
| 1.06E-36 | 1.049658 | dual specificity phosphatase 5 |
|
| 2.65E-46 | 1.102904 | EGF-like-domain, multiple 6 |
|
| 4.46E-49 | 1.133815 | ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
| 3.21E-26 | 1.498001 | ecotropic viral integration site 2B |
|
| 3.37E-37 | 1.249936 | Fc fragment of IgG, low affinity IIb, receptor (CD32) |
|
| 1.95E-29 | 1.132553 | Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
|
| 3.23E-56 | 1.342826 | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
|
| 3.76E-25 | 1.011778 | ficolin (collagen/fibrinogen domain containing) 1 |
|
| 9.33E-45 | 1.455488 | Fc receptor-like 5 |
|
| 1.09E-31 | 1.402519 | Fc receptor-like A |
|
| 1.04E-46 | 1.42036 | FK506 binding protein 11 |
|
| 1.75E-44 | 1.290024 | FBJ murine osteosarcoma viral oncogene homolog |
|
| 5.87E-36 | 1.14025 | hemoglobin, alpha 1 |
|
| 2.79E-44 | 1.210277 | hematopoietic cell-specific Lyn substrate 1 |
|
| 5.84E-58 | 1.159802 | heat shock protein 70kDa family, member 13 |
|
| 1.63E-43 | 1.347935 | intercellular adhesion molecule 2 |
|
| 3.07E-65 | 2.336454 | immunoglobulin lambda-like polypeptide 5 |
|
| 3.18E-43 | 1.354325 | interleukin 10 receptor, alpha |
|
| 2.82E-38 | 1.092466 | interleukin 1 beta |
|
| 6.34E-45 | 1.100459 | interleukin 2 receptor, gamma |
|
| 7.28E-47 | 1.184677 | integral membrane protein 2C |
|
| 6.48E-49 | 1.286419 | joining chain of multimeric IgA and IgM |
|
| 6.21E-59 | 1.652774 | lymphocyte transmembrane adaptor 1 |
|
| 6.74E-45 | 1.12351 | lymphocyte antigen 96 |
|
| 9.12E-20 | 1.282694 | membrane metallo-endopeptidase |
|
| 3.92E-57 | 1.025763 | matrix metallopeptidase 1 |
|
| 5.57E-59 | 1.466344 | matrix metallopeptidase 12 |
|
| 5.12E-54 | 1.178796 | matrix metallopeptidase 13 |
|
| 9.63E-57 | 1.040563 | matrix metallopeptidase 3 |
|
| 1.34E-34 | 1.51808 | matrix metallopeptidase 7 |
|
| 7.94E-43 | 2.407337 | marginal zone B and B1 cell-specific protein |
|
| 1.49E-21 | 1.195206 | neutrophil cytosolic factor 4 |
|
| 1.33E-48 | 1.483623 | odontogenic, ameloblast associated |
|
| 1.21E-32 | 1.215359 | purinergic receptor P2Y, G-protein coupled, 8 |
|
| 2.52E-23 | 1.289339 | PDZ domain containing ring finger 4 |
|
| 3.01E-28 | 1.098606 | platelet/endothelial cell adhesion molecule 1 |
|
| 4.14E-44 | 1.325032 | Pim-2 proto-oncogene, serine/threonine kinase |
|
| 3.25E-54 | 1.260461 | placenta specific 8 |
|
| 4.49E-46 | 1.43498 | plasminogen activator, tissue |
|
| 1.40E-51 | 1.0399 | phospholipid phosphatase 5 |
|
| 5.11E-71 | 1.387546 | prepronociceptin |
|
| 6.04E-52 | 2.388694 | POU class 2 associating factor 1 |
|
| 1.82E-22 | 1.041058 | pro-platelet basic protein |
|
| 4.58E-35 | 1.042763 | prokineticin 2 |
|
| 6.34E-57 | 1.07086 | protein tyrosine phosphatase type IVA, member 3 |
|
| 1.11E-43 | 1.173037 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
|
| 1.19E-45 | 1.196332 | regulator of G-protein signaling 1 |
|
| 3.12E-50 | 1.154445 | regulator of G-protein signaling 4 |
|
| 1.54E-47 | 1.262168 | ras homolog family member H |
|
| 8.98E-38 | 1.065063 | ribonuclease, RNase A family, k6 |
|
| 2.65E-37 | 1.005489 | SAM and SH3 domain containing 3 |
|
| 1.43E-54 | 1.097714 | sel-1 suppressor of lin-12-like 3 (C. elegans) |
|
| 4.59E-23 | 1.235928 | selectin E |
|
| 8.56E-43 | 1.199581 | selenoprotein M |
|
| 6.58E-22 | 1.458 | selectin L |
|
| 6.35E-12 | 1.038916 | serpin peptidase inhibitor, clade I (neuroserpin), member 1 |
|
| 9.20E-39 | 1.32865 | secreted frizzled-related protein 4 |
|
| 9.87E-41 | 1.619179 | SLAM family member 7 |
|
| 5.26E-38 | 2.09838 | sperm associated antigen 4 |
|
| 1.36E-66 | 1.043883 | serglycin |
|
| 8.80E-11 | 1.051981 | ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
|
| 1.73E-34 | 1.11477 | T-cell activation RhoGTPase activating protein |
|
| 3.19E-45 | 2.014512 | terminal nucleotidyltransferase 5C |
|
| 1.45E-45 | 1.330465 | thymocyte selection associated family member 2 |
|
| 2.93E-31 | 2.349733 | tumor necrosis factor receptor superfamily, member 17 |
|
| 2.92E-39 | 1.038621 | versican |
|
| 2.71E-48 | 1.062687 | zinc finger protein 275 |
|
| 3.00E-42 | -1.20712 | arylacetamide deacetylase |
|
| 1.08E-41 | -2.01688 | arylacetamide deacetylase-like 2 |
|
| 6.64E-33 | -1.16284 | ATP binding cassette subfamily A member 12 |
|
| 1.23E-53 | -1.14311 | ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2 |
|
| 3.48E-44 | -1.25704 | BPI fold containing family C |
|
| 6.56E-27 | -1.26108 | calmodulin-like 5 |
|
| 6.70E-54 | -1.28623 | claudin 20 |
|
| 6.96E-56 | -1.00726 | cordon-bleu WH2 repeat protein |
|
| 1.76E-37 | -2.14211 | desmocollin 1 |
|
| 1.09E-40 | -1.25365 | ELOVL fatty acid elongase 4 |
|
| 3.33E-36 | -1.09877 | epithelial cell adhesion molecule |
|
| 3.12E-50 | -1.02485 | family with sequence similarity 83, member C |
|
| 1.06E-18 | -1.22646 | filaggrin |
|
| 2.61E-27 | -1.68284 | filaggrin family member 2 |
|
| 7.92E-11 | -1.09036 | keratin 1, type II |
|
| 3.04E-17 | -1.5992 | keratin 2, type II |
|
| 1.67E-24 | -1.0645 | late cornified envelope 2B |
|
| 1.67E-14 | -1.32218 | loricrin |
|
| 7.12E-24 | -1.13528 | MAM domain containing 2 |
|
| 4.06E-49 | -1.21988 | neurofilament, light polypeptide |
|
| 3.87E-52 | -1.09761 | natriuretic peptide receptor 3 |
|
| 1.36E-48 | -1.08209 | premature ovarian failure, 1B |
|
| 4.38E-15 | -1.07675 | repetin |
|
| 5.53E-43 | -1.0713 | solute carrier family 16, member 9 |
|
| 8.89E-41 | -1.04423 | solute carrier family 19 (thiamine transporter), member 2 |
|
| 2.00E-37 | -1.26819 | solute carrier family 27 (fatty acid transporter), member 6 |
|
| 4.10E-51 | -1.19574 | sperm associated antigen 17 |
Fig 1A: Box plot, GSE10334 is shown in red and GSE16134 is shown in blue; B: PCA results before batch removal; C: PCA results after batch removal; D: Volcano plots, and |log2(FC)|>1, the over-expressed mRNAs are shown in red and the down-expressed mRNAs are shown in blue, the ordinate represents -log10 P-value; E: Hierarchical clustering analysis of mRNAs, different colors represent different expression trends, G1: Affected; G2: Unaffected.
Fig 3Ferroptosis-related gene expression heat map.
The expression trend in different samples were represented by different colors. * p-value < 0.05, **p-value < 0.01, ***p-value < 0.001. The significance of the two groups passed the Wilcox test.
Fig 4The abscissa represents gene ratio and the ordinate represents the enriched pathways.
GO analysis of potential targets of mRNAs. The cellular component, biological process, and molecular function of FRGs were clustered based on Cluster Profiler package (R version: 3.18.0). In the enrichment result, p-value <0.05 or false discovery rate (FDR) <0.05 is considered to be enriched to a meaningful pathway.
Fig 5Each bubble which represents an enriched function is according to the number of input genes in this term.
The size of the bubble represents the different significance levels. The different color of the bar and bubbles represent different modules, named C1-C8. If there are more than 5 terms in each module, top 5 with the highest enrich ratio will be displayed.
Fig 6Pathways by using ClueGO analysis, p-value<0.05.
Different pathways are represented by different colors.
Fig 7A: Various tissues, different tissues are represented by different colors; B: The functions of the TF targets, different functions are represented by different colors; C: The top 10 TFs.
Fig 8Significantly upregulated genes are marked in red and downregulated genes are marked in green.
The hub nodes connected to FRGs are represented by triangles.
Fig 9A: The ROC curves of ACSL4, CISD1, EMC2, FANCD2, FDFT1 and GPX4. B: The ROC curves of HSPA5, HSPB1, NCOA4, NFE2L2, RPL8 and SAT1. C: The ROC curves of SLC1A5, SLC7A11 and TFRC.
Fig 10The expression levels of the three FRGs between healthy control group (n = 6) and periodontitis group (n = 6).
All of the data are presented as means ± SD (p< 0.05).